78 related articles for article (PubMed ID: 10592921)
1. [Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].
Cario H; Stahnke K; Kohne E
Klin Padiatr; 1999; 211(6):431-7. PubMed ID: 10592921
[TBL] [Abstract][Full Text] [Related]
2. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
[TBL] [Abstract][Full Text] [Related]
3. Beta thalassemia major: the effect of age on glomerular filtration rate.
Malaki M; Sorkhabi RS; Shoaran M; Shafighe B
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):963-8. PubMed ID: 21912026
[TBL] [Abstract][Full Text] [Related]
4. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
Rafsanjani KA; Mafi N; Tafreshi RI
Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.
Albu A; Barbu CG; Antonie L; Vladareanu F; Fica S
Postgrad Med; 2014 Sep; 126(5):121-7. PubMed ID: 25295656
[TBL] [Abstract][Full Text] [Related]
6. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
[TBL] [Abstract][Full Text] [Related]
7. Assessment of iron overload in very young children with limited thalassemia care resources in South China.
Au WY; Li CF; Fang JP; Chen GF; Sun X; Li CG; Zhang XH; Wu XD; Gao HY; Hao WG; Rasalkar D; Deng M; Mok SP; Tricta F; Chu WC
Hemoglobin; 2014; 38(2):119-26. PubMed ID: 24502375
[TBL] [Abstract][Full Text] [Related]
8. Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran.
Rashid M; Karimi M
Transfus Med; 2012 Apr; 22(2):104-7. PubMed ID: 22212011
[TBL] [Abstract][Full Text] [Related]
9. Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major.
Bourli E; Dimitriadou M; Economou M; Vlachaki E; Christoforidis A; Maratou E; Stanopoulos I; Argyropoulou P; Aivazis V
Pediatr Pulmonol; 2012 Aug; 47(8):801-7. PubMed ID: 22328228
[TBL] [Abstract][Full Text] [Related]
10. Determinants of pulmonary hypertension in patients with Beta-thalassemia major and normal ventricular function.
Vlahos AP; Koutsouka FP; Papamichael ND; Makis A; Baltogiannis GG; Athanasiou E; Chaliasos N; Bourantas KL; Kolettis TM
Acta Haematol; 2012; 128(2):124-9. PubMed ID: 22846514
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous manifestations in Egyptian children with beta-thalassemia major: Relationship with serum ferritin, thyroid profile, and treatment modalities.
El-Dash H; Adel S
Pediatr Dermatol; 2018 Sep; 35(5):639-643. PubMed ID: 29943859
[TBL] [Abstract][Full Text] [Related]
12. Effect of iron chelator desferrioxamine on serum zinc levels in patients with beta thalassemia major.
Sultan S; Irfan SM; Kakar J; Zeeshan R
Malays J Pathol; 2015 Apr; 37(1):35-8. PubMed ID: 25890611
[TBL] [Abstract][Full Text] [Related]
13. [Clinico-biological and immunohaematological profile of patients with β-thalassemia in Tunisia: about 26 cases].
Romdhane H; Amara H; Abdelkefi S; Souyeh N; Chakroun T; Jarrey I; Bouslama M; Belhedi S; Houissa B; Boughammoura L; Jemni Yacoub S
Transfus Clin Biol; 2014 Dec; 21(6):309-13. PubMed ID: 25458984
[TBL] [Abstract][Full Text] [Related]
14. Higher Serum Ferritin Levels Correlate with an Increased Risk of Cutaneous Morbidity in Adult Patients with β-Thalassemia: A Single-Center Retrospective Study.
Skandalis K; Vlachos C; Pliakou X; Gaitanis G; Kapsali E; Bassukas ID
Acta Haematol; 2016; 135(2):124-30. PubMed ID: 26509267
[TBL] [Abstract][Full Text] [Related]
15. The Cutoff of Ferritin for Evaluation of Hypothyroidism in Patients With Thalassemia.
Baghersalimi A; Rad AH; Koohmanaee S; Darbandi B; Mirzaee MM; Aminzadeh V; Medghalchi A; Dalili S
J Pediatr Hematol Oncol; 2019 Oct; 41(7):515-518. PubMed ID: 31008807
[TBL] [Abstract][Full Text] [Related]
16. Ferritin thresholds for cardiac and liver hemosiderosis in β-thalassemia patients: a diagnostic accuracy study.
Darvishi-Khezri H; Aliasgharian A; Naderisorki M; Kosaryan M; Ghazaiean M; Fallah H; Zahedi M; Karami H
Sci Rep; 2022 Oct; 12(1):17996. PubMed ID: 36289264
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major.
Najafipour F; Aliasgarzadeh A; Aghamohamadzadeh N; Bahrami A; Mobasri M; Niafar M; Khoshbaten M
Ann Saudi Med; 2008; 28(5):361-6. PubMed ID: 18779644
[TBL] [Abstract][Full Text] [Related]
18. Spectrum Of HBB Gene Variants And Major Endocrine Complications In Thalassemia Patients Of Pakistan.
Ghafoor MB; Ujjan ID; Waryah AM; Memon FA
J Pak Med Assoc; 2023 Oct; 73(10):2013-2016. PubMed ID: 37876062
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Endocrinopathies in Turkish Children With β-Thalassemia Major: A Single-Center Study.
Altincik A; Akin M
J Pediatr Hematol Oncol; 2016 Jul; 38(5):389-93. PubMed ID: 27164531
[TBL] [Abstract][Full Text] [Related]
20. Endocrinopathies in beta-thalassemia major. Prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia.
Habeb AM; Al-Hawsawi ZM; Morsy MM; Al-Harbi AM; Osilan AS; Al-Magamsi MS; Zolaly MA
Saudi Med J; 2013 Jan; 34(1):67-73. PubMed ID: 23299162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
